相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microglial calcium signaling in the adult, aged and diseased brain
Bianca Brawek et al.
CELL CALCIUM (2013)
Caspases Playing in the Field of Neuroinflammation: Old and New Players
Jose L. Venero et al.
DEVELOPMENTAL NEUROSCIENCE (2013)
The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress
Kelvin C. Luk et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Neural and Immune Mechanisms in the Pathogenesis of Parkinson's Disease
Fabio Blandini
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Anti-apoptotic and Anti-inflammatory effect of Piperine on 6-OHDA induced Parkinson's Rat model
Pallavi Shrivastava et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Caspase-2 and caspase-8 trigger caspase-3 activation following 6-OHDA-induced stress in human dopaminergic neurons differentiated from ReNVM stem cells
Zohara L. Chaudhry et al.
NEUROLOGICAL RESEARCH (2013)
Microglia: Scapegoat, Saboteur, or Something Else?
Adriano Aguzzi et al.
SCIENCE (2013)
Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease
M. Decressac et al.
EXPERIMENTAL NEUROLOGY (2012)
Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson's disease: linking to Akt/GSK3β signaling pathway
Li Gong et al.
JOURNAL OF NEUROCHEMISTRY (2012)
NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease
Daniel Martinez-Fong et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE
J. Bove et al.
NEUROSCIENCE (2012)
Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase
Norelle C. Wildburger et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Identification of N-Propylnoraporphin-11-yl 5-(1,2-Dithiolan-3-yl)pentanoate as a New Anti-Parkinson's Agent Possessing a Dopamine D2 and Serotonin 5-HT1A Dual-Agonist Profile
Hai Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
6-OHDA generated ROS induces DNA damage and p53-and PUMA-dependent cell death
Alison I. Bernstein et al.
MOLECULAR NEURODEGENERATION (2011)
Caspase signalling controls microglia activation and neurotoxicity
Miguel A. Burguillos et al.
NATURE (2011)
Lithium Fails to Protect Dopaminergic Neurons in the 6-OHDA Model of Parkinson's Disease
Yue Yong et al.
NEUROCHEMICAL RESEARCH (2011)
TIME-COURSE OF NIGROSTRIATAL NEURODEGENERATION AND NEUROINFLAMMATION IN THE 6-HYDROXYDOPAMINE-INDUCED AXONAL AND TERMINAL LESION MODELS OF PARKINSON'S DISEASE IN THE RAT
S. Walsh et al.
NEUROSCIENCE (2011)
Knockdown of glycogen synthase kinase 3 beta attenuates 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells
Yi Li et al.
NEUROSCIENCE LETTERS (2011)
Neurodegeneration and Inflammation in Parkinson's disease
Sudarshan Phani et al.
PARKINSONISM & RELATED DISORDERS (2011)
Dissociation of Progressive Dopaminergic Neuronal Death and Behavioral Impairments by Bax Deletion in a Mouse Model of Parkinson's Diseases
Tae Woo Kim et al.
PLOS ONE (2011)
GFAP in health and disease
J. Middeldorp et al.
PROGRESS IN NEUROBIOLOGY (2011)
Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease
Calivarathan Latchoumycandane et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
GSK-3 mouse models to study neuronal apoptosis and neurodegeneration
Raquel Gomez-Sintes et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
New Therapeutic Strategy for Parkinson's and Alzheimer's Disease
E. Esposito et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders
Makoto Naoi et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression
Maria Clara Pott Godoy et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Chronic expression of low levels of tumor necrosis factor-α in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation
Ana Laura De Lella Ezcurra et al.
NEUROBIOLOGY OF DISEASE (2010)
Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease
Lilia Marinova-Mutafchieva et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons
Agnes Petit-Paitel et al.
PLOS ONE (2009)
Differential activation of PKCδ in the substantia nigra of rats following striatal or nigral 6-hydroxydopamine lesions
Katharine Hanrott et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Glycogen synthase kinase-3β regulates ΔNp63 gene transcription through the β-catenin signaling pathway
Wing-Keung Chu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3
Allison D. Ebert et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
NF-κB contributes to 6-hydroxydopainine-induced apoptosis of nigral dopaminergic neurons through p53
Zhong-Qin Liang et al.
BRAIN RESEARCH (2007)
Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model
Fabio Blandini et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats
Juan A. Gonzalez-Barrios et al.
MOLECULAR THERAPY (2006)
Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: Implications for abnormal motor behavior
V. Anaya-Martinez et al.
NEUROSCIENCE (2006)
A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCδ) protects against dopaminergic neuronal degeneration in Parkinson's disease models
Anumantha G. Kanthasamy et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Method of specific detection of apoptosis using formamide-induced DNA denaturation assay
Yuko Ito et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease
V. D. Nair
APOPTOSIS (2006)
Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease
SC Biswas et al.
NEUROCHEMICAL RESEARCH (2005)
Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice
SI Iwata et al.
SYNAPSE (2004)
Correlation between nucleocytoplasmic transport and caspase-3-dependent dismantling of nuclear pores during apoptosis
M Kihlmark et al.
EXPERIMENTAL CELL RESEARCH (2004)
Astroglial and microglial activation in the Wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine
RWP Rodrigues et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2004)
6-hydroxydopamine increases the level of TNFα and bax mRNA in the striatum and induces apoptosis of doparninergic neurons in hemiparkinsonian rats
A Mladenovic et al.
BRAIN RESEARCH (2004)
Class III β-tabulin isotype:: A key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology
CD Katsetos et al.
JOURNAL OF CHILD NEUROLOGY (2003)
Mitochondrial control of neuron death and its role in neurodegenerative disorders
J Jordán et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2003)
Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. A review.
RM Kostrzewa et al.
NEUROTOXICITY RESEARCH (2003)
Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat
MJ Martí et al.
BRAIN RESEARCH (2002)
The GSK3β signaling cascade and neurodegenerative disease
MD Kaytor et al.
CURRENT OPINION IN NEUROBIOLOGY (2002)
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease
D Blum et al.
PROGRESS IN NEUROBIOLOGY (2001)
Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat:: Similarities with cell loss in Parkinson's disease
M Rodríguez et al.
EXPERIMENTAL NEUROLOGY (2001)
Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death
DAE Cross et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Identification of apoptotic cells by formamide-induced DNA denaturation in condensed chromatin
OS Frankfurt et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2001)
Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion
K Tsuboi et al.
BRAIN RESEARCH (2000)
Review on apoptosis vs. necrosis of substantia nigrapars compacta in parkinson's disease
Richard M. Kostrzewa
NEUROTOXICITY RESEARCH (2000)
6-hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra
Y He et al.
BRAIN RESEARCH (2000)
分享论文
